Chronic pelvic pain--traditional and novel therapies: part II medical therapy

Review public-domain-us
View on PubMed
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-13 ⓘ

This paper discusses conventional and novel medical therapies for chronic pelvic pain, highlighting sympathetic nervous system defects as a common etiology and sympathomimetic amine therapy as potentially effective.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

PURPOSE: To describe medical therapeutic options for chronic pelvic pain. Furthermore to describe some new concepts in the etiology of chronic pelvic pain leading to some novel therapies. METHODS: The benefits and risks of various medical treatments for chronic pelvic pain including central pain, cyclic pain, vulvar pain and bladder pain are discussed. RESULTS: Among various conventional therapies the medical therapy with the most benefit with the least risks are low-dose impeded androgens, oral contraceptives, or low dosage progesterone/progestins. CONCLUSIONS: The various types of pelvic pain may all be different manifestations of a common etiology related to defects in the sympathetic nervous system. Sympathomimetic amine therapy may be the most effective therapy with the least side-effects. However, at the moment this schedule II drug has not been approved for this use and thus must be used off-label.

My notes (saved in your browser only)

Condition tags

endometriosischronic_pelvic_pain

MeSH descriptors

Pelvic Pain Chronic Disease Chronic Disease Endometriosis Endometriosis Endometriosis Female Female Hormones Hormones Hormones Humans Humans Pelvic Pain Pelvic Pain Pelvic Pain

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-10-11T09:27:45.537177+00:00
pubmed
last seen: 2026-10-08T21:09:19.025198+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine